from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0480c/-

LFCtreatmentdescriptionclass of inhibitor

0.829

Amikacinug/mL Amikacintranslation

1.168

Cap5-10ug/mL Capreomycintranslation

1.681

Rox10-50 ug/mL Roxithromycintranslation

-0.049

SM2-5 ug/mL Streptomycintranslation

0.530

Tet5-10 ug/mL Tetracyclinetranslation

-0.103

Rif0.2-5ug/mL Rifampicintranscription

0.156

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.459

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.136

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.019

CPZ10-50 ug/mL Chlorpromazinerespiration

0.398

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.150

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.083

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.097

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.727

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.459

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.016

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.287

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.036

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.909

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.503

KCN5-20 ug/mL Potassium cyaniderespiration

0.930

NaN30.2-2 mM Sodium aziderespiration

1.240

Nigericin50 uM Nigericinrespiration

-0.375

TRC10-150 ug/mL Triclosanrespiration

0.254

TRZ10-25 ug/mL Thioridazinerespiration

-0.474

Valinomycin0.5-10 uM Valinomycinrespiration

1.146

ZnSO42 mM ZnSO4respiration

0.665

menadione6-10 ug/mL Menadionerespiration

0.643

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.464

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.253

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.296

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.077

NRP_1Non-replicating persistence stage 1dosRassociated

0.940

Amp0.2mg/mL AmpicillincellWall

0.040

Cephalexin20-100 ug/mL CephalexincellWall

0.623

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.181

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.470

EMB10-20 ug/mL EthambutolcellWall

-0.527

Eta12-40 ug/mL EthionamidecellWall

-0.088

INH0.2-0.4 ug/mL IsoniazidcellWall

0.016

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.309

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.558

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.413

BZA0.12 mg/mL BenzamidearomaticAmides

-0.762

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.521

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.216

H2O24 mM hydrogen peroxideDNAdamaging

0.047

Levo10 ug/mL LevofloxacinDNAdamaging

0.670

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.704

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.027

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.365

UVUV-irradiationDNAdamaging

-0.702

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.166

Antimycin12.5-50 ug/mL Antimycin A?

0.142

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.196

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.258

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.276

PA8240.2-2 ug/mL PA-824?

-0.901

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.493

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.283

Verapamil50 uM Verapamil?

0.093

mercaptoethanol2 mM 2-Mercaptoethanol?

0.368

methoxatin10-20 ug/mL Methoxatin?